Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy

Eric Lawitz, Eliot Godofsky, Regine Rouzier, Thomas Marbury, Tuan Nguyen, June Ke, Mei Mei Huang, Jens Praestgaard, Denise Serra, Thomas G. Evans

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences